BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 279 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2021. The put-call ratio across all filers is 1.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $256,503,898 | +23.3% | 2,379,884 | +8.5% | 0.01% | +22.2% |
| Q1 2024 | $207,999,712 | -7.0% | 2,192,702 | -9.5% | 0.01% | -18.2% |
| Q4 2023 | $223,608,208 | +69.6% | 2,424,200 | -7.7% | 0.01% | +57.1% |
| Q3 2023 | $131,858,988 | -16.6% | 2,625,627 | +4.9% | 0.01% | -12.5% |
| Q2 2023 | $158,189,158 | +27.6% | 2,502,993 | -9.2% | 0.01% | +14.3% |
| Q1 2023 | $123,960,002 | -50.1% | 2,755,279 | -51.4% | 0.01% | 0.0% |
| Q4 2022 | $248,395,778 | +69.8% | 5,669,842 | +155.4% | 0.01% | -22.2% |
| Q3 2022 | $146,262,000 | +6.6% | 2,219,798 | -18.3% | 0.01% | +12.5% |
| Q2 2022 | $137,213,000 | -5.2% | 2,716,542 | +19.8% | 0.01% | +14.3% |
| Q1 2022 | $144,809,000 | -21.9% | 2,266,894 | +30.9% | 0.01% | -22.2% |
| Q4 2021 | $185,458,000 | +6.8% | 1,731,470 | +2.6% | 0.01% | 0.0% |
| Q3 2021 | $173,583,000 | +19.7% | 1,688,384 | +2.4% | 0.01% | +12.5% |
| Q2 2021 | $145,068,000 | -1.7% | 1,649,246 | +8.7% | 0.01% | 0.0% |
| Q1 2021 | $147,547,000 | -19.3% | 1,517,505 | -7.0% | 0.01% | -27.3% |
| Q4 2020 | $182,920,000 | +8.8% | 1,631,027 | -10.1% | 0.01% | 0.0% |
| Q3 2020 | $168,092,000 | +14.5% | 1,813,288 | -3.6% | 0.01% | 0.0% |
| Q2 2020 | $146,784,000 | +28.1% | 1,881,846 | -4.0% | 0.01% | +10.0% |
| Q1 2020 | $114,612,000 | -23.6% | 1,959,841 | +4.7% | 0.01% | 0.0% |
| Q4 2019 | $150,024,000 | +11.5% | 1,872,722 | +2.3% | 0.01% | 0.0% |
| Q3 2019 | $134,537,000 | -12.8% | 1,831,186 | +11.9% | 0.01% | -16.7% |
| Q2 2019 | $154,357,000 | +44.4% | 1,636,349 | +22.5% | 0.01% | +50.0% |
| Q1 2019 | $106,919,000 | +29.2% | 1,335,649 | -13.0% | 0.01% | 0.0% |
| Q4 2018 | $82,753,000 | -37.1% | 1,535,024 | -8.9% | 0.01% | -20.0% |
| Q3 2018 | $131,549,000 | +12.1% | 1,685,200 | -8.9% | 0.01% | 0.0% |
| Q2 2018 | $117,394,000 | -17.7% | 1,849,283 | +18.9% | 0.01% | -16.7% |
| Q1 2018 | $142,641,000 | +25.9% | 1,555,523 | +3.5% | 0.01% | +33.3% |
| Q4 2017 | $113,292,000 | +11.8% | 1,502,406 | +3.3% | 0.01% | 0.0% |
| Q3 2017 | $101,315,000 | +42.8% | 1,454,159 | +3.9% | 0.01% | +50.0% |
| Q2 2017 | $70,936,000 | +124.0% | 1,400,035 | +76.8% | 0.01% | +100.0% |
| Q1 2017 | $31,663,000 | +65.6% | 791,739 | +16.1% | 0.00% | +50.0% |
| Q4 2016 | $19,125,000 | +98.8% | 681,891 | +110.6% | 0.00% | +100.0% |
| Q3 2016 | $9,619,000 | +46.0% | 323,802 | -0.5% | 0.00% | 0.0% |
| Q2 2016 | $6,587,000 | +171.4% | 325,396 | +142.4% | 0.00% | – |
| Q1 2016 | $2,427,000 | -28.8% | 134,258 | +3.8% | 0.00% | – |
| Q4 2015 | $3,407,000 | +37.5% | 129,306 | +11.3% | 0.00% | – |
| Q3 2015 | $2,477,000 | +22.1% | 116,176 | +51.6% | 0.00% | – |
| Q2 2015 | $2,029,000 | – | 76,630 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 781,539 | $49,925,000 | 7.34% |
| CADIAN CAPITAL MANAGEMENT, LP | 1,921,347 | $122,736,000 | 6.13% |
| Casdin Capital, LLC | 1,550,000 | $99,014,000 | 4.44% |
| DAFNA Capital Management LLC | 246,280 | $15,732,000 | 4.10% |
| Nextech Invest Ltd. | 188,228 | $12,024,000 | 3.43% |
| Eagle Health Investments LP | 170,551 | $10,895,000 | 2.68% |
| Integral Health Asset Management, LLC | 153,000 | $9,774,000 | 2.54% |
| Boxer Capital, LLC | 507,374 | $32,411,000 | 1.67% |
| Rock Springs Capital Management LP | 947,715 | $60,540,000 | 1.52% |
| EFG Asset Management (North America) Corp. | 136,691 | $8,730,000 | 1.31% |